title: Immunohistochemical analysis of PDK1 expression in breast cancer.
abstract: BACKGROUND
  3-phosphoinositide-dependent protein kinase-1 (PDK1) functions downstream of phosphoinositide 3-kinase (PIK3) and activates members of the AGC family of protein kinases that are known to play crucial roles in physiological processes associated with cell metabolism, growth, proliferation and survival. Changes in the expression and activity of PDK1 and several AGC kinases have been linked to human disease, including cancer.
  
  
  METHODS
  We used immunohistochemical analysis to determine PDK1 expression in 241 tumors from patients with breast cancer in which we had previously analyzed PIK3CA mutation status.
  
  
  RESULTS
  Moderate or high expression of PDK1 was observed in 213 of the 241 cases (88%). There was no correlation between PIK3CA mutation status and PDK1 overexpression.
  
  
  CONCLUSIONS
  Our findings indicate that PDK1 is independently activated in breast cancer and not only as part of the PIK3CA pathway, suggesting that PDK1 plays a specific and distinct role from the canonical PIK3/Akt pathway and promotes oncogenesis independently of AKT. Our data implicate PDK-1 and downstream components of the PDK-1 signaling pathway as promising therapeutic targets for the treatment of breast cancer.
authors.affiliation: Institute of Pathology Charité, University Hospital Berlin, 10117 Berlin, Germany. ruza.arsenic@charite.de.
authors.forename: Ruza
authors.initials: R
authors.lastname: Arsenic
mesh_terms: D064413:3-Phosphoinositide-Dependent Protein Kinases / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000235:genetics; D001943:Breast Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D058534:Class I Phosphatidylinositol 3-Kinases; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor; D019869:Phosphatidylinositol 3-Kinases; D058534:Class I Phosphatidylinositol 3-Kinases; C484760:PIK3CA protein, human; D064413:3-Phosphoinositide-Dependent Protein Kinases; C578562:PDPK1 protein, human
references.citation: Cancer Cell. 2009 Jul 7;16(1):21-32
references.pmid: 19573809
references.citation: Br J Cancer. 2013 Jan 15;108(1):170-8
references.pmid: 23321518
references.citation: Curr Biol. 2005 Oct 25;15(20):1839-46
references.pmid: 16243031
references.citation: Haematologica. 2014 May;99(5):858-64
references.pmid: 24334295
references.citation: Cancer Res. 2009 Aug 1;69(15):6299-306
references.pmid: 19602588
references.citation: Blood. 2007 May 15;109(10):4461-9
references.pmid: 17255356
references.citation: Diagn Pathol. 2013 Aug 02;8:129
references.pmid: 23915145
references.citation: Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):50-6
references.pmid: 24471188
references.citation: Cancer Cell. 2013 Mar 18;23(3):406-20
references.pmid: 23453624
references.citation: Cancer Cell. 2010 Nov 16;18(5):459-71
references.pmid: 21075311
references.citation: Cancer Manag Res. 2013 Aug 23;5:271-80
references.pmid: 24039447